Brainsway Ltd.
Brainsway Ltd is a Healthcare company operating in Medical Devices with a $597.5M market cap.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-06-21.
Transcripts
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks BWAY's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BWAY.
$ curl https://api.spokenalpha.com/v1/companies/BWAYFAQ
Spoken Alpha indexes BWAY's earnings call transcripts at https://spokenalpha.com/companies/BWAY. Each call links to attributed speakers and parsed analyst Q&A. Brainsway Ltd.'s own investor relations page is at https://investors.brainsway.com/.
Brainsway Ltd. (BWAY) operates in the Healthcare sector (Medical Devices industry).
Repeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.59 | $3.55 | -27.1% | -4.9% | -5.0% |
| Q4 FY2026 | $2.81 | $3.54 | -20.7% | -6.0% | -7.7% |
| Q3 FY2026 | $3.16 | $3.80 | -16.9% | +2.0% | +1.5% |
| Q2 FY2026 | $2.76 | $3.62 | -23.8% | -6.6% | -7.0% |
| Q1 FY2025 | $2.66 | $3.73 | -28.8% | -6.4% | -7.7% |
| Q4 FY2025 |
| $2.73 |
| $3.79 |
| -28.1% |
| +0.2% |
| -0.2% |
| Q3 FY2025 | $2.84 | $3.63 | -21.8% | +3.7% | +1.1% |
| Q2 FY2025 | $3.00 | $3.84 | -21.8% | -6.1% | -6.9% |
| Q1 FY2024 | $2.76 | $3.67 | -24.9% | +2.0% | +1.4% |
| Q4 FY2024 | $3.31 | $3.88 | -14.6% | +2.0% | +0.5% |